Clinical Trials

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05640817 2026-02-06

Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer

90 enrolled

Pentoxifylline, Cisplatin, Nephrotoxixcity

NCT01495676 2025-10-10

GETUGV04

69 enrolled 9 charts

Genitourinary

Urinary Bladder Neoplasms

NCT01326468 2025-09-25

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Head and Neck Neoplasms

NCT04016389 2025-08-12

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

31 enrolled

Uterine Cervical Neoplasms

NCT06292286 2025-06-11

SCENIC

18 enrolled

Ovarian Neoplasms

NCT04823468 2025-06-10

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

236 enrolled

Nasopharyngeal Carcinoma, Body Weight

NCT01369641 2025-05-16

The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy

1 enrolled 6 charts

Tumor-Agnostic

Neoplasms

NCT05857631 2025-04-15

PARCERII

90 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06558682 2025-04-01

Neoadjuvant Therapy in Cervical Cancer

48 enrolled

Uterine Cervical Neoplasms

NCT06480864 2025-01-06

Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer

38 enrolled

Small Cell Lung Carcinoma

NCT02512692 2024-11-18

Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma

6 enrolled

Cholangiocarcinoma

NCT06611345 2024-10-26

A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers

60 enrolled

Phase NA Not yet recruiting

Biliary Tract Neoplasms

NCT06649448 2024-10-18

EF-001

200 enrolled

Other solid neoplasm

Solid Tumor Cancer

NCT06349044 2024-08-27

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

120 enrolled

Phase NA Active not recruiting

Carcinoma, Hepatocellular

NCT03306901 2024-05-23

ASSURE

240 enrolled

Esophageal Neoplasms

NCT02072148 2024-05-06

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

112 enrolled 11 charts

Squamous Cell Carcinoma of Head and Neck

NCT00502463 2024-02-07

ASOG-HNO1

51 enrolled

Head and Neck Neoplasms

NCT05916690 2024-01-19

Electrochemotherapy for the Treatment of Vulvar Cancer

20 enrolled

Phase NA Enrolling by invitation

Vulvar Neoplasms

NCT06048926 2023-09-21

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

30 enrolled

Esophageal Squamous Cell Carcinoma

NCT00968799 2023-08-08

Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study

6 enrolled 7 charts

Carcinoma, Ovarian Epithelial, Hyperthermia, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence

NCT03214003 2023-06-22

TRISS

235 enrolled

Small Cell Lung Cancer Limited Stage

NCT01755897 2023-05-09

CC-01

337 enrolled

Uterine Cervical Neoplasms

NCT05800054 2023-04-05

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

210 enrolled

Esophageal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05717790 2023-02-08

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

288 enrolled

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma

NCT05667415 2022-12-28

Treatment of Advance Gastric Cancer With Disulfiram

40 enrolled

Chemotherapy；Advanced Gastric Cancer；Cisplatin；Disulfiram

NCT05352321 2022-07-01

Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma

264 enrolled

Nasopharyngeal Carcinoma

NCT00883480 2022-06-13

SLAT

153 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04772001 2022-05-18

Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

53 enrolled

Uterine Cervical Neoplasms

NCT02289807 2021-10-15

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Nasopharyngeal Carcinoma

NCT01016561 2021-05-05

Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer

12 enrolled

Uterine Cervical Neoplasms

NCT02177838 2021-04-21

Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer

8 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

NCT02778308 2021-04-06

Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma

100 enrolled

Gallbladder Neoplasms

NCT02624531 2021-01-07

SYSUGO-005

60 enrolled

Uterine Cervical Neoplasms

NCT03909776 2021-01-05

Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma

99 enrolled

Sarcoma

Osteosarcoma

NCT03981068 2020-09-25

DAHANCA 37. Re-irradiation With Proton Radiotherapy

20 enrolled

Head and Neck Neoplasms, Recurrence

NCT02627807 2020-06-16

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

386 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT00058370 2020-05-11

Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma

6 enrolled 8 charts

CNS

Medulloblastoma, Central Nervous System Neoplasms

NCT04017377 2020-04-28

VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical Cancer

15 enrolled

Uterine Cervical Neoplasms

NCT02786719 2020-03-12

SPRING

13 enrolled 13 charts

CNS

Neuroblastoma

NCT04284215 2020-02-25

Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC

68 enrolled

Efficacy and Safety

NCT03559803 2019-01-22

A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer

58 enrolled

Uterine Cervical Neoplasms

NCT03671538 2018-09-17

Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin

62 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT02358863 2018-09-06

mEGA

13 enrolled 6 charts

Esophageal Neoplasms, Stomach Neoplasms

NCT03360760 2018-08-28

Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum

100 enrolled

Sarcoma

Osteosarcoma

NCT01275664 2018-05-22

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

4 enrolled 5 charts

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

NCT03413358 2018-01-29

Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid

240 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02944357 2017-11-17

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Genitourinary

Infiltrating Bladder Urothelial Carcinoma

NCT02382068 2017-11-09

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Ototoxicity, Neoplasms

NCT00580983 2016-09-07

Optimized Intensity Modulated Irradiation for Head and Neck Cancer

90 enrolled 11 charts